Amryt Pharma Share Chat (AMYT)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Amryt Pharma	LSE:AMYT	London	Ordinary Share	GB00BDD1LS57	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	21.75p	21.00p	22.50p	21.75p	21.75p	21.75p	81,177	06:30:09

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	1.2	-6.7	-4.1	-	45.31

Amryt Pharma Share Discussion Threads

Showing 1426 to 1450 of 1450 messages

Chat Pages: 58 57 56 55 54 53 52 51 50 49 48 47 Older

Date	Subject	Author	Discuss
20/7/2017 09:16	150k traded by 9am shows that several people were quietly watching and waiting to pounce. It will be interesting to see if a larger delayed trade also appears in due course.Similar action on another of my holdings yesterday. I guess it's that time of year - seems to come round annually!	tightfist	Read Full Thread Reply
20/7/2017 09:02	tightfist - I was thinking the same thing. There was a late reported trade for many days and seemed to be mopping up the sells.	solomon	Read Full Thread Reply
19/7/2017 20:24	Is a Buy order being progressively filled at around 21.5p? On reported trades over the last few days there seems to be an appetite to continuingly mop-up what look to be Sells at 21.04p, whilst the Buy price remains relatively unchanged.	tightfist	Read Full Thread Reply
19/7/2017 20:18	Amryt will be presenting at Pro-Active investors in London Mayfair on 5th October.	tightfist	Read Full Thread Reply
19/7/2017 10:42	Hi Pap,Yes, it's sleepy season when minimal volumes and take us quickly in either direction..... I would like to add to my holding but am sitting back looking for a compelling opportunity. If it doesn't happen at AMYT it will happen somewhere else. After years of Feast & Famine investing I am a lot more disciplined now on the size and number of my speculative positions!Having said that I do like the combination of Lojuxta cash flow, the 20m loan and the ongoing drug trials.Cheers, tightfist	tightfist	Read Full Thread Reply
18/7/2017 19:20	Just 29k of AMYT shares traded today. Miniscule volume. Just 8 trades all day. For a total spend of under £6,000. Absolutely NO current investor interest in AMYT!	papillon	Read Full Thread Reply
17/7/2017 17:07	Well tightfist, we are currently resting on the lower Bollinger Band and the 14 day RSI is very oversold so I'm expecting a bounce up towards the upper BB (currently 27p) even without news as "bargain hunters" see an opportunity. As you say it's a quiet time of the year for investors so it wouldn't take much buying to push up the share price I added last week and am tempted to add again (I only top up in small amounts and have set myself a strict limit on how much I want to invest in AMYT). ATB.	papillon	Read Full Thread Reply
17/7/2017 16:24	Sadly we are rapidly closing-in to the 21p level I mused about in post 1277. Hopefully support is just around the corner but this is a pretty quiet time of the year......	tightfist	Read Full Thread Reply
17/7/2017 14:43	10 small trades so far today (some very small), 9 sells at 21.10p and 21.00p and just one buy at 21.70p (below mid price at the time).	papillon	Read Full Thread Reply
16/7/2017 12:35	My latest AMYT log chart. I'm hopeful that the horizontal line shown by my arrow and the 200 day EMA will act as support for the share price The 14 day RSI is currently "oversold", but it could stay "oversold" for sometime yet. Need to see a rising RSI again. Similarly the MACD is still bearish, but it looks poised to me, rather like the RSI, to turn bullish again, but when is the 64,000 dollar question? Need good news to be issued for these 2 indicators to turn bullish again? Possibly! I had a small top up last week; might do the same again soon. It could be a good time to gamble and accumulate an AMYT stake rather than wait for good news and buy into the spike? I think so, but buying AMYT shares is still a speculative gamble; potentially high reward, but definitely still high risk. free stock charts from uk.advfn.com	papillon	Read Full Thread Reply
16/7/2017 11:32	Many thanks for your reply, Icebreaker. Oh, to have been a fly on the wall at that meeting! As it is we'll just have to remain ignorant of why the meeting took place, why it took place, what was discussed and what, if any, was the outcome. I'm hopeful that the AMYT share price will turn out to be a 10 bagger from the low of last year sometime within the next 2 years. I'm obviously indulging in wishful thinking as I can't predict the future! I hope I'm not being a "Walter Mitty" fantasist such as we see posting on so many of these AIM company advfn bb's. I'am still prepared to sell my AMYT shares if my charts turn negative; one thing I'm determined to do is be a rationalist and NOT fall in love with the company! I'm definitely NOT an AMYT "believer". It would be nice if, as you posted yesterday, we hear news, such as another licesing deal, or an update on Lojuxta sales, before the interim results are issued in around 2 months. Fingers crossed!	papillon	Read Full Thread Reply
16/7/2017 09:38	Hi Papillon and Greendragon Apologies for the cryptic post. The meeting took place in April and the source was Joe Wiley. I cannot give further details but if you were to email the company I believe they would confirm that the meeting took place. The subject of the meeting was not disclosed to me. Best wishes IB	icebreaker	Read Full Thread Reply
16/7/2017 04:58	Thanks for joining the discussion Icebreaker, very interesting comments indeed. Papillon has asked the key questions, if this meeting was requested by Amgen it would be very significant. Are we about to turn the corner Paps? :-)	greendragon777	Read Full Thread Reply
15/7/2017 23:00	Hi Icebreaker. " As an outside shot, there could be some interest from Amgen (major competitor who I do know they have recently met)" That's a very interesting comment. Assuming your source (are you the source?) is reliable do you know who requested this meeting? Was it AMYT, or was it Amgen and what was the reason for the meeting? I realise that you probably can't answer these questions; still if you can then I, for one, would be interested in your answers. Amgen has 19,200 employees, revenue (2016) of US$23bn and a Mkt Cap of US$126.7bn (June 2017). Bit of a difference with AMYT! A giant compared with a tiddler!	papillon	Read Full Thread Reply
15/7/2017 20:52	What has happened to timbo003 and the notes mentioned in his post at 1228? Would be very useful for those unable to attend the Shard presentation.	kinkell	Read Full Thread Reply
15/7/2017 19:27	Hi Pap and GD You are not alone - if it helps. I am personally hoping for either a new alliance or an increased estimate of Lojuxta sales before September. As an outside shot, there could be some interest from Amgen (major competitor who I do know they have recently met). Personally I am not anticipating exiting under £1. If it doesn't get there fine, I'm not over exposed. Have a good weekend, IB	icebreaker	Read Full Thread Reply
15/7/2017 12:08	At the current share price AMYT looks great value and definitely worth a speculative buy, IMO. At 21p (I don't think it will drop below 21p because that would signify a potentially bearish double top chart pattern had formed), I agree greendragon, it's worth rummaging down the back of the sofa and breaking open the piggy bank to find the cash to top up as AMYT looks to be a stonking speculative buy at that price, IMO. Unfortunately we seem to be rather alone in having that opinion, greendragon! LOL. However watch the "herd" pile in on the next RNS (hopefully a good one!) causing a resulting spike up in the sp! That's the way these speculative AIM shares work; the share price gradually drifts down until the next good news is issued when the "herd" (momentum speculators, traders and AMYT "fans") pile in. Once that initial enthusiam wanes the share price drifts back down (sometimes it comes back down to Earth rather quicker when the investors realise the news is not as good as it initially appeared) and so the cycle repeats itself ad infinitum! LOL. If the story is a good one (as I currently believe it to be at AMYT) the longer term overall direction of the share price is up; if the story is not a good one (CTAG is a good example, LOGP another) the overall share price trend over the longer term is down despite the occasional big spikes up on apparently good news being issued. I had a small top up this week and will do so again if it drops back down towards 21p. I will sell (hopefully!) these particular shares on the next spike up (fingers crossed!)	papillon	Read Full Thread Reply
15/7/2017 08:02	Are we there yet, are we there yet.....I keep looking at the date to see if it's mid September yet! haha Cant come quick enough now to arrest this slide! If it does slide to 20p I'm gonna have to find some cash somewhere to do a bit of a topuperooney! :-)	greendragon777	Read Full Thread Reply
14/7/2017 19:18	Miniscule volume today. Will support at 22p hold? If not the next support level is at circa 21p. Edited: 15/7/17. I believe the next support level is at 21p (and not 20p), if the current 22p support fails to hold. I think a drop back down to 20p would form a potentially bearish double top chart pattern.	papillon	Read Full Thread Reply
12/7/2017 19:33	When you put it like that Paps it really is incredible that it's not trading higher. But I think you observations could be very relevant with regards early hunters looking for a quick buck and having lost interest now. It is also perhaps a little bit early for any of the larger institutional investors/funds etc as it won't be making profit for a while and as you know those guys generally don't do 'long term' as they are judged on their recent performances etc. I'm guessing it will be at least next year before any of that type of money comes in unless something radical happens in the meantime. As you say, it's sit and wait now for more good news.....we'll just have to keep screaming it from the rooftops what a little gem this is in hiding until PI's sit up and take notice! Haha	greendragon777	Read Full Thread Reply
12/7/2017 19:15	Many thanks, greendragon. Pity I can't generate any investor interest in AMYT! LOL. I find it amazing that the AMYT share price is still below last years placing price of 24p. This despite the fact there has been no dilution and probably none likely before next years first results of the AP101 trials (due to the 20m Euro EIB loan). When AMYT listed last year a further placing and extra dilution was on the cards to help pay for the trials. We've had nothing, but good news since AMYT listed. First the EIB 20m Euro loan on very favourable terms and the Lojuxta licensing deal for the "EEA", North Africa, Middle East, Turkey & Israel (a vast potential market, especially the EU with a population of 506m) which provided AMYT with an instant revenue stream. Then the further good news on Lojuxta's efficacy and it's forecast of 10.5m Euro revenue for 2017. Add in that Novelion are forecasting US$80-85m net revenue from Juxtapid for 2017 and AMYT is capable of increasing that 10.5m Euro revenue for Lojuxta in 2018 and subsequent years. Yet the AMYT share price languishes below last years placing price, becalmed in the doldrums! I can understand the selling; there are always sellers especially those who bought FAST shares at much higher prices, who have no interest in a biotech/pharma and have only held on this long in the hope of a higher exit price and have finally given up and fancy having a speculative gamble on O&G explorers like PVR & UKOG. It's the absence of buyers that is puzzling me, despite all the good news, bullish broker notes and ramping by ShareProphets (numerous HSR tips). AMYT has not captured the imagination of PI's! We'll just have to wait for further good news!	papillon	Read Full Thread Reply
12/7/2017 18:39	You're a wealth of knowledge on this stock Papillon, thanks for sharing all your observations as always.	greendragon777	Read Full Thread Reply
12/7/2017 12:02	The quoted spread of 22-23p is a complete NONSENSE! Someone this morning sold 40,178 @ 21.10p and then someone presumably bought 44,988 @ 22.20p. 2 other, smaller trades, were presumably sells at 22.01 and 22.00p.	papillon	Read Full Thread Reply
11/7/2017 19:02	My latest AMYT log chart showing two uptrend lines. One failed earlier this month. Will the other provide support? We'll soon find out because the share price is currently just above it. free stock charts from uk.advfn.com	papillon	Read Full Thread Reply
11/7/2017 14:44	Many thanks, bigwavedave. It looks like AMYT is going to be worth buying sometime before the interims are released sometime in September (probably mid September as per last year) in expectation of an update that Lojuxta sales are running ahead of forecasts. When to buy? When will the AMYT share price bottom out and at what price? Those are the questions that need answering! I have no answers, unfortunately! I'm guessing in the range circa 20-21. Worth keeping an eye on any potentially bullish candlestick patterns forming, plus a rising 14 day RSI and when the MACD & Ichimoku turn bullish again. Best of luck at picking the bottom!	papillon	Read Full Thread Reply

Chat Pages: 58 57 56 55 54 53 52 51 50 49 48 47 Older